» Articles » PMID: 32117966

Asparaginyl-tRNA Synthetase, a Novel Component of Hippo Signaling, Binds to Salvador and Enhances Yorkie-Mediated Tumorigenesis

Overview
Specialty Cell Biology
Date 2020 Mar 3
PMID 32117966
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aminoacyl-tRNA synthetases (ARSs), which are essential for protein translation, were recently shown to have non-translational functions in various pathological conditions including cancer. However, the molecular mechanism underlying the role of ARSs in cancer remains unknown. Here, we demonstrate that asparaginyl-tRNA synthetase (NRS) regulates Yorkie-mediated tumorigenesis by binding to the Hippo pathway component Salvador. and the NRS inhibitor tirandamycin B (TirB) suppressed Yorkie-mediated tumor phenotypes in . Genetic analysis showed that interacted with Salvador, and activated Hippo target genes by regulating Yorkie phosphorylation. Biochemical analyses showed that NRS blocked Salvador-Hippo binding by interacting directly with Salvador, and TirB treatment inhibited NRS-Salvador binding. YAP target genes were upregulated in a mammalian cancer cell line with high expression of NRS, whereas TirB treatment suppressed cancer cell proliferation. These results indicate that NRS regulates tumor growth by interacting with Salvador in the Hippo signaling pathway.

Citing Articles

Bacteriocin production enhancing mechanism of RX-8 response to Y-5 by transcriptomic and proteomic analyses.

Nie R, Zhu Z, Qi Y, Wang Z, Sun H, Liu G Front Microbiol. 2023; 14:1111516.

PMID: 36910197 PMC: 9998909. DOI: 10.3389/fmicb.2023.1111516.


Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.

Galindo-Feria A, Notarnicola A, Lundberg I, Horuluoglu B Front Immunol. 2022; 13:866087.

PMID: 35634293 PMC: 9136399. DOI: 10.3389/fimmu.2022.866087.


Engineering P450 TamI as an Iterative Biocatalyst for Selective Late-Stage C-H Functionalization and Epoxidation of Tirandamycin Antibiotics.

Espinoza R, Caddell Haatveit K, Grossman S, Tan J, McGlade C, Khatri Y ACS Catal. 2022; 11(13):8304-8316.

PMID: 35003829 PMC: 8739753. DOI: 10.1021/acscatal.1c01460.


The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle.

de Amorim I, de Sousa Rodrigues M, Mencalha A J Cancer Res Clin Oncol. 2021; 147(5):1287-1297.

PMID: 33580421 DOI: 10.1007/s00432-021-03552-3.


Roles of Aminoacyl-tRNA Synthetases in Cancer.

Zhou Z, Sun B, Nie A, Yu D, Bian M Front Cell Dev Biol. 2020; 8:599765.

PMID: 33330488 PMC: 7729087. DOI: 10.3389/fcell.2020.599765.

References
1.
Yu Z, Vodanovic-Jankovic S, Ledeboer N, Huang S, Rajski S, Kron M . Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase. Org Lett. 2011; 13(8):2034-7. PMC: 3074013. DOI: 10.1021/ol200420u. View

2.
Delarue M . Aminoacyl-tRNA synthetases. Curr Opin Struct Biol. 1995; 5(1):48-55. DOI: 10.1016/0959-440x(95)80008-o. View

3.
Park S, Schimmel P, Kim S . Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A. 2008; 105(32):11043-9. PMC: 2516211. DOI: 10.1073/pnas.0802862105. View

4.
Zhao B, Li L, Lei Q, Guan K . The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010; 24(9):862-74. PMC: 2861185. DOI: 10.1101/gad.1909210. View

5.
Rho S, Kim M, Lee J, Seol W, MOTEGI H, Kim S . Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex. Proc Natl Acad Sci U S A. 1999; 96(8):4488-93. PMC: 16359. DOI: 10.1073/pnas.96.8.4488. View